Abstract
R-loops are critical for gene regulation but their contribution to human Mendelian disorders has not been explored. We show that in rare disease cohorts de novo variants are highly prevalent in genomic regions which form R-loops. Using this insight, we demonstrate that variants in two novel disorder genes, RNU2-2P and RNU5B-1, together with the recently described RNU4-2 provide a genetic explanation for an exceptionally large proportion of individuals with suspected rare Mendelian disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive direct funding although the authors acknowledge Solve-RD and the Wellcome trust who have funded PhD students who worked on this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Genomics England has approval from the HRA Committee East of England Cambridge South (REC Ref 14/EE/1112). This specific project was approved for publication by the Genomics England Research Registry (RR1147)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in this study was accessed through the Genomics England Research Environment or Solve-RD RD-CONNECT platform. Access to these datasets can be granted to approved researchers pending review by the appropriate board.
